Alexion Receives Positive Opinion from EU’s CHMP for Soliris to Treat Subgroup of gMG Patients
Alexion Pharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has…
Get regular updates to your inbox.